bioAffinity Technologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
BIAF Key Statistics
Stock Snapshot
As of today, bioAffinity Technologies(BIAF) shares are valued at $0.67. The company's market cap stands at 4.38M, with a P/E ratio of -0.07.
As of 2026-07-13, bioAffinity Technologies(BIAF) stock has fluctuated between $0.61 and $0.77. The current price stands at $0.67, placing the stock +10.1% above today's low and -12.5% off the high.
The bioAffinity Technologies(BIAF)'s current trading volume is 430.52K, compared to an average daily volume of 585.06K.
In the last year, bioAffinity Technologies(BIAF) shares hit a 52-week high of $13.50 and a 52-week low of $0.61.
In the last year, bioAffinity Technologies(BIAF) shares hit a 52-week high of $13.50 and a 52-week low of $0.61.
BIAF News
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
bioAffinity Technologies (BIAF) announced continued acceleration in commercial sales for CyPath Lung, its noninvasive lung cancer diagnostic, with more than 200...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.